Medical Xpress news

Type 1 diabetes is widely understood as an autoimmune disease, with the immune system attacking the insulin-producing beta cells of the pancreas. But two new studies suggest those cells may be more than passive victims. Together, ...

Better identification and management of sleep apnea and associated vascular risk factors in midlife may provide an important opportunity to support long-term brain health, according to new research from Monash University.

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a new T-cell immunotherapy for children and young adults with some of the deadliest brain tumors, ...

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time. When injected into mouse models of retinal disease, ...

Diabetes opens people to other noncommunicable diseases like obesity, retinopathy and cardiovascular diseases like heart attacks and hypertension. A recent study by researchers at the University of Virginia School of Medicine ...

For a vaccine to be effective, it must do two things. First, it must trigger an immune response. Second, the vaccine must train the body to remember the response so it can fight that same disease in the future. Now, new research ...

As teenagers increasingly turn to artificial intelligence chatbots for advice about friendships, family conflicts and romantic ties, researchers are raising concerns that the technology could disrupt how young people learn ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and weight-loss management, but they have also led to some unfortunate outcomes. A recent study in JAMA ...

Scientists at the University of Oklahoma have identified a previously unrecognized immune system pathway that helps explain how cigarette smoking increases the risk of cardiovascular disease. The findings, published in Circulation ...

Adelaide University researchers have carried out the first in-human trial of a new type of treatment for a leading cause of blindness in working age adults, with promising results.

Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.

The autoimmunity associated with type 1 diabetes often begins in the first years of life, and the diagnosis of type 2 diabetes is rapidly rising among children and teens.